Collect

3.0 mL whole blood in lavender-top (EDTA) tube(s)

Specimen Required

1.0 mL whole blood

Specimen Min Vol

0.5 mL whole blood

Specimen Preparation

None

Storage/Transport Temperature

Refer to Specimen stability criteria as shown below

Ambient

72 hours

Refrigerated

7 days

Frozen

14 days

Unacceptable Conditions

Specimens that exceed stated stability, unlabeled/mislabeled/mismatched specimens, specimens submitted in leaking containers

Special Instructions

This test requires its own lavender top. Collecting sample just before the next dose will be adequate for monitoring purposes. Optimal response to Cyclosporine is usually associated with the trough blood concentration (i.e., the minimum concentration experienced just before the next dose).

CPT Codes

80158

Synonyms

  • Neoral
  • Sandimmune

Methodology

Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS)

Performing Location

Chemistry (Toxicology)

Reported STAT

2 hours

Reported Routine

6 hours

Additional Information

This test was performed using liquid chromatography tandem mass spectrometry. This test was developed and its performance characteristics were determined by the University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use. 

Test set up frequency

Daily (Cut-off time 12:00 Noon)

Reference Interval


Liver Transplants, suggested therapeutic ranges: 
<6 Months post tranplant: 300-400 ng/mL
>6 Months post transplant: 150-250 ng/mL
>1 Year post transplant: 100-200 ng/mL

Rental Transplant: 100-400 ng/mL
Cardiac Tranplant: 100-400 ng/mL
Bone Marrow Transplant: 200-300 ng/mL
Critical Value (automatic call-back): > 450 ng/mL

Additional Information

This test was performed using liquid chromatography tandem mass spectrometry. This test was developed and its performance characteristics were determined by the University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use. 
Collection

Collect

3.0 mL whole blood in lavender-top (EDTA) tube(s)

Specimen Required

1.0 mL whole blood

Specimen Min Vol

0.5 mL whole blood

Specimen Preparation

None

Storage/Transport Temperature

Refer to Specimen stability criteria as shown below

Ambient

72 hours

Refrigerated

7 days

Frozen

14 days

Unacceptable Conditions

Specimens that exceed stated stability, unlabeled/mislabeled/mismatched specimens, specimens submitted in leaking containers

Special Instructions

This test requires its own lavender top. Collecting sample just before the next dose will be adequate for monitoring purposes. Optimal response to Cyclosporine is usually associated with the trough blood concentration (i.e., the minimum concentration experienced just before the next dose).
Test Info

CPT Codes

80158

Synonyms

  • Neoral
  • Sandimmune

Methodology

Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS)

Performing Location

Chemistry (Toxicology)

Reported STAT

2 hours

Reported Routine

6 hours

Additional Information

This test was performed using liquid chromatography tandem mass spectrometry. This test was developed and its performance characteristics were determined by the University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use. 

Test set up frequency

Daily (Cut-off time 12:00 Noon)
Result Interpretation

Reference Interval


Liver Transplants, suggested therapeutic ranges: 
<6 Months post tranplant: 300-400 ng/mL
>6 Months post transplant: 150-250 ng/mL
>1 Year post transplant: 100-200 ng/mL

Rental Transplant: 100-400 ng/mL
Cardiac Tranplant: 100-400 ng/mL
Bone Marrow Transplant: 200-300 ng/mL
Critical Value (automatic call-back): > 450 ng/mL

Additional Information

This test was performed using liquid chromatography tandem mass spectrometry. This test was developed and its performance characteristics were determined by the University of California Irvine Medical Center, Department of Pathology and Laboratory Medicine. It has not been approved by the FDA, however, approval is not required for clinical use. 
NICU/Pediatric Info